Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 4201-4210 of 10980

Edit search filters
  1. A Study to Evaluate the Effectiveness of The Portable Organ Care System (OCS™) Heart from Donors After Circulatory Death Heart

    Jacksonville, FL

  2. Testicular Tissue Cryopreservation in Children

    Rochester, MN

  3. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer

  4. A Study to Compare Total Amount of Opioid Use in the First 72 Hours Following Vaginal Hysterectomy Surgery

  5. Integrative Cognitive-Affective Therapy for Adolescent Eating Disorders

    Rochester, MN

  6. Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients

    Rochester, MN

  7. IL-4 and Insulin Resistance for Treatment of Patients with Atopic Dermatitis

    Scottsdale/Phoenix, AZ

  8. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ

  9. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies

    Rochester, MN

  10. TAS-102 in Treating Advanced Biliary Tract Cancers

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer